通合科技(300491.SZ)2020年淨利升38.28%至4149.73萬元 擬10派0.25元
格隆匯3月29日丨通合科技(300491.SZ)披露2020年年度報吿,報吿期內,公司實現營業總收入3.21億元,同比增長15.85%;歸屬於上市公司股東的淨利潤4149.73萬元,同比增長38.28%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1400.83萬元,同比下降37.71%;基本每股收益0.26元,年報推10派現金紅利0.25元(含税)。
報吿期內,儘管受到新冠疫情的不利影響,公司經營團隊踐行“有追求、能創造、敢擔當”的使命要求,調動一切積極因素,充分發揮自身的營銷推廣和技術研發優勢,實現了智能電網、新能源汽車和軍工裝備三大戰略領域營業收入的全面增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.